Health ❯ Nutrition ❯ Obesity

Weight Loss

Weight Loss Injections Semaglutide GLP-1 Drugs Lean Mass Preservation Weight Stigma Body Fat Weight-Loss Drugs Anti-Obesity Drugs Ultra-Processed Foods Pharmaceuticals Muscle Mass Interventions Medication Diet Culture Energy Expenditure Adipose Tissue Biological Factors Metabolic Processes Surgery Health Policies Processed Food GLP-1 Treatments

GLP-1 Drugs Reshape Obesity Care

High prices, patchy insurance, temporary policy fixes limit patient access to GLP-1 medicines.

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

New Data Tie GLP-1 Drugs’ Broad Benefits to Inflammation

Novo Nordisk Survey Finds Wegovy Users Report Sharp Drop in ‘Food Noise’

Triple-Dose Semaglutide Outperforms Standard Regimen in Weight-Loss Trials